Post by
HermannHaller on Feb 23, 2023 7:18am
Q4 results
All looks good, incl dividend raise and positive commentary on the outlook for 2023.
Revenue for Q4 was $78.8 million (vs Cormark est of $77.5)
EBITDA was $15.3 million (Cormark $15.0)
EPS for the year $1.15, vs Cormark at $1.09. I have to admit my estimate was higher, but the company had the disruption from the plant relocation in Q4.
GLTA
Comment by
HermannHaller on Feb 23, 2023 10:08am
Also, net debt to EBITDA ended the year at 0.9x (see page 9 of MD&A). This was better than 1.0x at end of prior year, despite the Royal acquisition. This company makes gobs of cash, there is absolutely no need for an equity issue.
Comment by
Jambalaya54 on Feb 23, 2023 10:45am
Right you are, although today's initial reaction to really solid results and a substantial dividend increase are luke warm to say the very least, Unless there is total collapse in momentum I don't see any reason that Supremex can't reach Cormack's estimate of $9:15 a share before year end.